In a clinical study of children (aged 6–12) with ADHD, Vyvanse demonstrated ADHD symptom control at 1.5 hours and even 13 hours after taking it.*
*Based on Swanson, Lotkin, Agler, M. Flynn and Pelham Deportment Scores (SKAMP-DS).
Duration of ADHD symptom control has not been studied in teens (aged 13–17) taking Vyvanse.
Vyvanse is not for weight loss. It is not known if Vyvanse is safe and effective for the treatment of obesity.
In kids ages 6 to 12 with ADHD, Vyvanse provided ADHD symptom control. Vyvanse is not for weight loss. It is not known if Vyvanse is safe and effective for the treatment of obesity.
In one study in kids ages 6 to 12:
Based on Swanson, Kotkin, Agler, M. Flynn, and Pelham Deportment Scores (SKAMP-DS).
In another clinical study in kids ages 6 to 12:
‡Based on Conners’ Parent Rating Scale.
Duration of ADHD symptom control has not been studied in teens.
Your child should not take Vyvanse if he or she:
Your child should take Vyvanse in the morning exactly as the doctor tells him or her to take it.
Before starting Vyvanse and during treatment, tell your child's doctor about all health conditions (or a family history of), including:
Please be advised that Shire Pharmaceuticals has no control over the content or presentation of the site you are about to view
You are being directed to another website.
Linking to the Vitals website is provided as a resource to our visitors and does not imply an endorsement or recommendation of a particular physician by Shire Pharmaceuticals, nor an endorsement of any Shire product by any physician located using the Vitals physician finder. All prescription decisions are at the sole discretion of the physician. Shire Pharmaceuticals accepts no responsibility or liability for the content of or the services provided via the Vitals website.